{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:24:16Z","timestamp":1707524656361},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,30]]},"DOI":"10.7759\/cureus.30881","type":"journal-article","created":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T20:33:06Z","timestamp":1667161986000},"source":"Crossref","is-referenced-by-count":0,"title":["Does Prophylactic Oral Zinc Reduce the Risk of Contracting COVID-19?"],"prefix":"10.7759","author":[{"given":"Sean D","family":"Adrean","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caleb","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ash","family":"Pirouz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hema L","family":"Ramkumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"V'kovski P","year":"2021","unstructured":"V'kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. 2021, 19:155-70. 10.1038\/s41579-020-00468-6","journal-title":"Nat Rev Microbiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2020.00018","article-title":"COVID-19 and liver dysfunction: current insights and emergent therapeutic strategies","volume":"8","author":"Feng G","year":"2020","unstructured":"Feng G, Zheng KI, Yan QQ, et al.. COVID-19 and liver dysfunction: current insights and emergent therapeutic strategies. J Clin Transl Hepatol. 2020, 8:18-24. 10.14218\/JCTH.2020.00018","journal-title":"J Clin Transl Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa200776","article-title":"Remdesivir for the treatment of COVID-19 - preliminary report","volume":"383","author":"McMahon JH","year":"2020","unstructured":"McMahon JH, Udy A, Peleg AY. Remdesivir for the treatment of COVID-19 - preliminary report. N Engl J Med. 2020, 383:992-3. 10.1056\/NEJMoa200776","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Horby P","year":"2021","unstructured":"Horby P, Lim WS, Emberson JR, et al.. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021, 384:693-704. 10.1056\/NEJMoa2021436","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2032369","article-title":"FDA approval of remdesivir - a step in the right direction","volume":"383","author":"Rubin D","year":"2020","unstructured":"Rubin D, Chan-Tack K, Farley J, Sherwat A. FDA approval of remdesivir - a step in the right direction. N Engl J Med. 2020, 383:2598-600. 10.1056\/NEJMp2032369","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19","volume":"384","author":"Sadoff J","year":"2021","unstructured":"Sadoff J, Gray G, Vandebosch A, et al.. Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. N Engl J Med. 2021, 384:2187-201. 10.1056\/NEJMoa2101544","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey M","year":"2021","unstructured":"Voysey M, Clemens SA, Madhi SA, et al.. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021, 397:99-111. 10.1016\/S0140-6736(20)32661-1","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2108891","article-title":"Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant","volume":"385","author":"Lopez Bernal J","year":"2021","unstructured":"Lopez Bernal J, Andrews N, Gower C, et al.. Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant. N Engl J Med. 2021, 385:585-94. 10.1056\/NEJMoa2108891","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-020-02437-9","article-title":"Zinc and COVID-19: basis of current clinical trials","volume":"199","author":"Pal A","year":"2021","unstructured":"Pal A, Squitti R, Picozza M, et al.. Zinc and COVID-19: basis of current clinical trials. Biol Trace Elem Res. 2021, 199:2882-92. 10.1007\/s12011-020-02437-9","journal-title":"Biol Trace Elem Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2016.03.022","article-title":"Zinc and immunity: an essential interrelation","volume":"611","author":"Maares M","year":"2016","unstructured":"Maares M, Haase H. Zinc and immunity: an essential interrelation. Arch Biochem Biophys. 2016, 611:58-65. 10.1016\/j.abb.2016.03.022","journal-title":"Arch Biochem Biophys"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3945\/an.112.003038","article-title":"Zinc biochemistry: from a single zinc enzyme to a key element of life","volume":"4","author":"Maret W","year":"2013","unstructured":"Maret W. Zinc biochemistry: from a single zinc enzyme to a key element of life. Adv Nutr. 2013, 4:82-91. 10.3945\/an.112.003038","journal-title":"Adv Nutr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00775-011-0797-4","article-title":"Zinc homeostasis and signaling in health and diseases: zinc signaling","volume":"16","author":"Fukada T","year":"2011","unstructured":"Fukada T, Yamasaki S, Nishida K, Murakami M, Hirano T. Zinc homeostasis and signaling in health and diseases: zinc signaling. J Biol Inorg Chem. 2011, 16:1123-34. 10.1007\/s00775-011-0797-4","journal-title":"J Biol Inorg Chem"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/0148607115572193","article-title":"Safety and dose escalation study of intravenous zinc supplementation in pediatric critical illness","volume":"40","author":"Cvijanovich NZ","year":"2016","unstructured":"Cvijanovich NZ, King JC, Flori HR, Gildengorin G, Vinks AA, Wong HR. Safety and dose escalation study of intravenous zinc supplementation in pediatric critical illness. JPEN J Parenter Enteral Nutr. 2016, 40:860-8. 10.1177\/0148607115572193","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1331\/1544-3191.44.5.594.hulisz","article-title":"Efficacy of zinc against common cold viruses: an overview","volume":"44","author":"Hulisz D","year":"2004","unstructured":"Hulisz D. Efficacy of zinc against common cold viruses: an overview. J Am Pharm Assoc (2003). 2004, 44:594-603. 10.1331\/1544-3191.44.5.594.hulisz","journal-title":"J Am Pharm Assoc (2003)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.3.783-790.2004","article-title":"Effect of zinc salts on respiratory syncytial virus replication","volume":"48","author":"Suara RO","year":"2004","unstructured":"Suara RO, Crowe JE Jr. Effect of zinc salts on respiratory syncytial virus replication. Antimicrob Agents Chemother. 2004, 48:783-90. 10.1128\/AAC.48.3.783-790.2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001176","article-title":"Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture","volume":"6","author":"te Velthuis AJ","year":"2010","unstructured":"te Velthuis AJ, van den Worm SH, Sims AC, Baric RS, Snijder EJ, van Hemert MJ. Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathog. 2010, 6:e1001176. 10.1371\/journal.ppat.1001176","journal-title":"PLoS Pathog"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/advances\/nmz013","article-title":"The role of zinc in antiviral immunity","volume":"10","author":"Read SA","year":"2019","unstructured":"Read SA, Obeid S, Ahlenstiel C, Ahlenstiel G. The role of zinc in antiviral immunity. Adv Nutr. 2019, 10:696-710. 10.1093\/advances\/nmz013","journal-title":"Adv Nutr"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3945\/an.116.013177","article-title":"The age-related eye disease 2 study: micronutrients in the treatment of macular degeneration","volume":"8","author":"Gorusupudi A","year":"2017","unstructured":"Gorusupudi A, Nelson K, Bernstein PS. The age-related eye disease 2 study: micronutrients in the treatment of macular degeneration. Adv Nutr. 2017, 8:40-53. 10.3945\/an.116.013177","journal-title":"Adv Nutr"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2020.04.028","article-title":"Investigate oral zinc as a prophylactic treatment for those at risk for COVID-19","volume":"216","author":"McPherson SW","year":"2020","unstructured":"McPherson SW, Keunen JE, Bird AC, Chew EY, van Kuijk FJ. Investigate oral zinc as a prophylactic treatment for those at risk for COVID-19. Am J Ophthalmol. 2020, 216:A5-6. 10.1016\/j.ajo.2020.04.028","journal-title":"Am J Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.119.10.1417","article-title":"A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8","volume":"119","author":"Age-Related Eye Disease Study Research Group","year":"2001","unstructured":"Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001, 119:1417-36. 10.1001\/archopht.119.10.1417","journal-title":"Arch Ophthalmol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li W","year":"2003","unstructured":"Li W, Moore MJ, Vasilieva N, et al.. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003, 426:450-4. 10.1038\/nature02145","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-047474","article-title":"Zinc for the prevention or treatment of acute viral respiratory tract infections in adults: a rapid systematic review and meta-analysis of randomised controlled trials","volume":"11","author":"Hunter J","year":"2021","unstructured":"Hunter J, Arentz S, Goldenberg J, et al.. Zinc for the prevention or treatment of acute viral respiratory tract infections in adults: a rapid systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2021, 11:e047474. 10.1136\/bmjopen-2020-047474","journal-title":"BMJ Open"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.06.082","article-title":"The minimal effect of zinc on the survival of hospitalized patients with COVID-19: an observational study","volume":"159","author":"Yao JS","year":"2021","unstructured":"Yao JS, Paguio JA, Dee EC, et al.. The minimal effect of zinc on the survival of hospitalized patients with COVID-19: an observational study. Chest. 2021, 159:108-11. 10.1016\/j.chest.2020.06.082","journal-title":"Chest"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.0369","article-title":"Effect of high-dose zinc and ascorbic acid supplementation vs usual care on symptom length and reduction among ambulatory patients with SARS-CoV-2 infection: the COVID A to Z randomized clinical trial","volume":"4","author":"Thomas S","year":"2021","unstructured":"Thomas S, Patel D, Bittel B, et al.. Effect of high-dose zinc and ascorbic acid supplementation vs usual care on symptom length and reduction among ambulatory patients with SARS-CoV-2 infection: the COVID A to Z randomized clinical trial. JAMA Netw Open. 2021, 4:e210369. 10.1001\/jamanetworkopen.2021.0369","journal-title":"JAMA Netw Open"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14826","article-title":"Zinc supplementation as an adjunct therapy for COVID-19: challenges and opportunities","volume":"87","author":"Chinni V","year":"2021","unstructured":"Chinni V, El-Khoury J, Perera M, et al.. Zinc supplementation as an adjunct therapy for COVID-19: challenges and opportunities. Br J Clin Pharmacol. 2021, 87:3737-46. 10.1111\/bcp.14826","journal-title":"Br J Clin Pharmacol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.2010.28674I","article-title":"Zinc bioavailability and homeostasis","volume":"91","author":"Hambidge KM","year":"2010","unstructured":"Hambidge KM, Miller LV, Westcott JE, Sheng X, Krebs NF. Zinc bioavailability and homeostasis. Am J Clin Nutr. 2010, 91:1478S-83S. 10.3945\/ajcn.2010.28674I","journal-title":"Am J Clin Nutr"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/nu12030762","article-title":"A guide to human zinc absorption: general overview and recent advances of in vitro intestinal models","volume":"12","author":"Maares M","year":"2020","unstructured":"Maares M, Haase H. A guide to human zinc absorption: general overview and recent advances of in vitro intestinal models. Nutrients. 2020, 12:762. 10.3390\/nu12030762","journal-title":"Nutrients"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2020.1786964","article-title":"COVID-19 and comorbidities: a systematic review and meta-analysis","volume":"132","author":"Gold MS","year":"2020","unstructured":"Gold MS, Sehayek D, Gabrielli S, Zhang X, McCusker C, Ben-Shoshan M. COVID-19 and comorbidities: a systematic review and meta-analysis. Postgrad Med. 2020, 132:749-55. 10.1080\/00325481.2020.1786964","journal-title":"Postgrad Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-020-01509-1","article-title":"Risk factors for Covid-19 severity and fatality: a structured literature review","volume":"49","author":"Wolff D","year":"2021","unstructured":"Wolff D, Nee S, Hickey NS, Marschollek M. Risk factors for Covid-19 severity and fatality: a structured literature review. Infection. 2021, 49:15-28. 10.1007\/s15010-020-01509-1","journal-title":"Infection"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/119536-does-prophylactic-oral-zinc-reduce-the-risk-of-contracting-covid-19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:43:24Z","timestamp":1707507804000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/119536-does-prophylactic-oral-zinc-reduce-the-risk-of-contracting-covid-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,30]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.30881","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,30]]}}}